Biomerica, Inc. (BMRA)
NASDAQ: BMRA · Real-Time Price · USD
0.355
-0.017 (-4.57%)
At close: Nov 4, 2024, 4:00 PM
0.350
-0.005 (-1.41%)
Pre-market: Nov 5, 2024, 4:48 AM EST

Biomerica Cash Flow Statement

Millions USD. Fiscal year is Jun - May.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Aug '24 May '24 May '23 May '22 May '21 May '20 2019 - 2015
Net Income
-6.16-5.98-7.14-4.53-7.45-2.34
Upgrade
Depreciation & Amortization
0.380.370.350.60.380.4
Upgrade
Loss (Gain) From Sale of Assets
---0.05--
Upgrade
Stock-Based Compensation
0.740.841.191.261.350.2
Upgrade
Provision & Write-off of Bad Debts
0-0.010.34-0.680.77-0
Upgrade
Other Operating Activities
-0.06-0.21-0.17-0.771.55-0.02
Upgrade
Change in Accounts Receivable
-0.12-0.22-0.291.37-0.46-0.31
Upgrade
Change in Inventory
-0.01-0.120.531.56-1.91-0.72
Upgrade
Change in Accounts Payable
0.380.25-0.080.39-0.4-0.01
Upgrade
Change in Other Net Operating Assets
-0.18-0.3-0.20.280.91-1.5
Upgrade
Operating Cash Flow
-5.03-5.36-5.47-0.48-5.25-4.3
Upgrade
Capital Expenditures
-0.03-0.05-0.06-0.06-0.14-0.03
Upgrade
Sale (Purchase) of Intangibles
-0.02-0.06-0.01-0.11-0.16-0.09
Upgrade
Investing Cash Flow
-0.05-0.12-0.08-0.17-0.3-0.12
Upgrade
Issuance of Common Stock
--10.12.481.2810.46
Upgrade
Other Financing Activities
-0.08-0.08-0.71-0.09-0.17-
Upgrade
Financing Cash Flow
-0.08-0.089.392.391.1112.37
Upgrade
Foreign Exchange Rate Adjustments
-00.01-0.04-0.03-0.01-0
Upgrade
Net Cash Flow
-5.17-5.553.81.72-4.447.95
Upgrade
Free Cash Flow
-5.06-5.41-5.54-0.54-5.39-4.33
Upgrade
Free Cash Flow Margin
-91.87%-99.94%-103.73%-2.84%-74.84%-64.71%
Upgrade
Free Cash Flow Per Share
-0.30-0.32-0.39-0.04-0.45-0.43
Upgrade
Cash Interest Paid
-----0
Upgrade
Cash Income Tax Paid
0.020.040.050.020.030.01
Upgrade
Levered Free Cash Flow
-2.66-3.14-2.651.07-2.45-3.34
Upgrade
Unlevered Free Cash Flow
-2.66-3.14-2.651.07-2.45-3.34
Upgrade
Change in Net Working Capital
-0.340.25-0.41-2.22-0.82.32
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.